Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

No treatment has been found which reverses long-standing neurological dysfunction in patients with multiple sclerosis (MS). Observations in animal models of MS show that immunoglobulins directed against CNS components promote oligodendroglial proliferation and new myelin synthesis. Preliminary studi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurol Neurosurg Psychiatry
Main Authors: Noseworthy, J H, O'Brien, P C, van Engelen, B G, Rodriguez, M
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 1994
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1016715/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7964842/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.57.suppl.11
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares